Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine

The increasing incidence of gonorrhea worldwide and the global spread of multidrug-resistant strains of Neisseria gonorrhoeae, constitute a public health emergency. With dwindling antibiotic treatment options, there is an urgent need to develop safe and effective vaccines. Gonococcal lipooligosaccha...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulati, Sunita, Shaughnessy, Jutamas, Ram, Sanjay, Rice, Peter A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400993/
https://www.ncbi.nlm.nih.gov/pubmed/30873172
http://dx.doi.org/10.3389/fimmu.2019.00321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400993/
https://www.ncbi.nlm.nih.gov/pubmed/30873172
http://dx.doi.org/10.3389/fimmu.2019.00321

Ejemplares similares